The study, published in the journal Scientific Reports, showed psilocybin affected two key areas of the brain. The amygdala - which is heavily involved in how we process emotions such as fear and ...

Psilocybin-assisted psychotherapy resulted in significant reductions in depression among clinicians who provided front-line COVID-19 care in 2020 and 2021. These reductions were measurably greater ...

Dr. Anthony Back, lead investigator on the psilocybin therapy study, is an oncologist, palliative care specialist and professor at the University of Washington School of Medicine in Seattle.

The company will provide Mātai with its GMP Full Spectrum Natural Psilocybin extract, and further track stability of the extract toward ensuring the highest standards of GMP quality and compliance.